Tesetaxel as First-line Therapy for Metastatic Breast Cancer

This study is currently recruiting participants.
Verified July 2012 by Genta Incorporated
Sponsor:
Information provided by (Responsible Party):
Genta Incorporated
ClinicalTrials.gov Identifier:
NCT01221870
First received: October 13, 2010
Last updated: July 20, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)